Drugmaker Divi’s Laboratories reported an 81% jump in first-quarter consolidated net profit at ₹492.06 crore.
In the year earlier period, it had reported a net profit of ₹272.44 crore.
The higher net profit came on the back of revenue from operations increasing 49% to ₹1,730.47 crore (₹1,162.88 crore).
Forex gain during the quarter was ₹5 crore as against a loss of ₹6 crore in the corresponding quarter of last year.
The company said it had near normal operations during the quarter, with minimal impact due to the COVID-19 pandemic.
While a significant part of ongoing capex programmes were completed in the last fiscal year, there was a delay in the completion of the balance work due to the non-availability of workmen with some contractors engaged for the projects, the firm said.